See more here:
Trading by management and close relations of management
GBT Announces New Employment Inducement Grants
See the original post:
GBT Announces New Employment Inducement Grants
Weblink Instructions for the Annual Meeting of Shareholders of Zivo Bioscience, Inc.
Bio-Path Holdings to Announce Third Quarter 2021 Financial Results on November 12, 2021
See the article here:
Bio-Path Holdings to Announce Third Quarter 2021 Financial Results on November 12, 2021
Ocugen Inc. Regains Compliance with Nasdaq Bid Price Rule
See the original post:
Ocugen Inc. Regains Compliance with Nasdaq Bid Price Rule
Berkeley Lights Reports Financial Results for Third Quarter of Fiscal Year 2020
Mustang Bio Reports Third Quarter 2020 Financial Results and Recent Corporate Highlights
Virbac : Declaration of the number of shares and voting rights October 2020
Read the rest here:
Virbac : Declaration of the number of shares and voting rights October 2020
SCYNEXIS Reports Third Quarter 2020 Financial Results and Provides Company Update
Braingrid Limited Announces Share Consolidation
Read the original:
Braingrid Limited Announces Share Consolidation
Monthly information on share capital and company voting rights
Here is the original post:
Monthly information on share capital and company voting rights
Genmab Announces Phase 3 Study Evaluating Epcoritamab in Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma
Golden Leaf Holdings Announces Resignation of President Stanley Grissinger
Originally posted here:
Golden Leaf Holdings Announces Resignation of President Stanley Grissinger
Latest Wound Care Research from Organogenesis Highlighted at SAWC Fall 2020 Virtual Meeting
Trillium Therapeutics Announces Formation of Scientific Advisory Board
Entera Bio to Present at the H.C. Wainwright 6th Annual Israel Conference
See the article here:
Entera Bio to Present at the H.C. Wainwright 6th Annual Israel Conference
Zenith Confirms Interim Filings on SEDAR
See the rest here:
Zenith Confirms Interim Filings on SEDAR
OliX Pharmaceuticals Announces FDA Clearance of the IND to Evaluate the Efficacy of OLX10010 in Phase 2a Clinical Trial for Hypertrophic Scars
XORTX Participation in Virtual Conferences
Read more from the original source:
XORTX Participation in Virtual Conferences